1. Entrectinib use in a platinum-refractory mucinous ovarian cancer harboring a NTRK3 gene fusion
   Olivia G. Beck et al, 2023, Gynecologic Oncology Reports CrossRef
2. Validation and interpretation of Pan-TRK immunohistochemistry: a practical approach and challenges with interpretation
   Cansu Karakas et al, 2024, Diagnostic Pathology CrossRef
3. Real‐world experience of tropomyosin receptor kinase inhibition with entrectinib in ETV6‐NTRK3 positive metastatic salivary secretory carcinoma: A case series
   Tomoya Yokota et al, 2023, Head & Neck CrossRef
4. NTRK Gene Fusions in Solid Tumors and TRK Inhibitors: A Systematic Review of Case Reports and Case Series
   Giovanni Maria Iannantuono et al, 2022, Journal of Personalized Medicine CrossRef